TD Asset Management Inc Decreases Stake in HCA Healthcare, Inc. $HCA

TD Asset Management Inc cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 522,648 shares of the company’s stock after selling 39,596 shares during the quarter. TD Asset Management Inc’s holdings in HCA Healthcare were worth $244,003,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the stock. Capital World Investors raised its stake in HCA Healthcare by 3.8% during the 3rd quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock valued at $2,113,662,000 after buying an additional 179,443 shares during the last quarter. Geode Capital Management LLC raised its stake in HCA Healthcare by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after buying an additional 13,565 shares during the last quarter. Norges Bank purchased a new stake in HCA Healthcare during the 4th quarter valued at $1,262,513,000. Arrowstreet Capital Limited Partnership increased its holdings in HCA Healthcare by 1.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock valued at $880,199,000 after buying an additional 36,414 shares during the last quarter. Finally, Viking Global Investors LP increased its holdings in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 0.9%

Shares of HCA stock opened at $364.00 on Thursday. The stock’s 50-day moving average price is $444.21 and its 200-day moving average price is $478.72. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The stock has a market capitalization of $80.75 billion, a price-to-earnings ratio of 12.52, a price-to-earnings-growth ratio of 1.16 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same period in the previous year, the company posted $6.45 earnings per share. HCA Healthcare’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.9%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Analysts Set New Price Targets

A number of analysts have commented on HCA shares. Mizuho upped their target price on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. TD Cowen reduced their target price on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a report on Monday, April 27th. Barclays reduced their target price on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a report on Monday, April 27th. JPMorgan Chase & Co. reduced their target price on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday, May 19th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $525.00 target price on shares of HCA Healthcare in a report on Friday, April 24th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $515.77.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.